Prehabilitation and continuous perioperative rehabilitation for patients undergoing lung resection for non-small cell lung cancer: a structured narrative review Authors: Yury S. Esakov, Evgeny A. Toneev, Andrei I. Gritsiuta, Vsevolod N. Galkin Published: 2026 ABSTRACT Background and ObjectiveLung resection remains the primary curative treatment for early-stage non-small cell lung cancer (NSCLC), but surgery is associated with postoperative pulmonary complications (PPCs) and impaired functional recovery. Prehabilitation may improve physiologic reserve before surgery, although its effects on postoperative morbidity and sustained functional outcomes remain incompletely defined. This structured narrative review summarizes current evidence on prehabilitation and continuous perioperative rehabilitation before lung resection for NSCLC, with emphasis on early postoperative morbidity, functional recovery, and risk-adapted implementation.MethodsThis structured narrative review used a PICO-informed scope, structured literature search, and thematic synthesis. PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, eLibrary, and professional society websites were searched for English- and Russian-language publications from January 2019 through February 2026. Earlier landmark studies were considered when methodologically important or necessary for clinical context. Review-level evidence and primary studies were synthesized separately, focusing on PPCs, length of hospital stay (LOS), preoperative functional changes, recovery to baseline, postoperative between-group differences, and sustained functional outcomes at 6 months or later.Key Content and FindingsEvidence was most consistent for PPCs. The 2022 Cochrane review reported a reduced risk with preoperative exercise interventions (RR 0.45; 95% CI: 0.33 to 0.61), and a 2025 meta-analysis reported a similar association (RR 0.39; 95% CI: 0.25 to 0.60). A recent multicenter randomized trial in high-risk patients showed that a 14-day multimodal program reduced PPCs and shortened hospital stay. Functional outcomes varied according to timing, endpoint definition, baseline risk, and whether rehabilitation continued after surgery. Evidence for a sustained independent effect of the preoperative phase alone remains limited.ConclusionsPrehabilitation before lung resection for NSCLC is most consistently associated with improved early pulmonary outcomes. Continuous perioperative rehabilitation may be more relevant to sustained functional recovery than isolated preoperative intervention. A risk-adapted perioperative rehabilitation framework may be clinically useful, but should be regarded as an author-proposed approach requiring prospective validation. Introduction Background Surgical resection remains the primary curative treatment for patients with early stage and resectable non-small cell lung cancer (NSCLC). Selection of the optimal treatment strategy depends not only on tumor stage, technical resectability, and available systemic therapies, but also on the patient’s functional operability (1). For thoracic surgeons, assessment of physiologic reserve has independent clinical importance, as the patient’s ability to tolerate the planned extent of pulmonary resection largely determines the safety of surgery and the feasibility of completing multimodality oncologic treatment (2). In patients with lung cancer, physiologic reserve is frequently limited by chronic obstructive pulmonary disease (COPD), emphysema, smoking history, sarcopenia, advanced age, impaired exercise tolerance, and cardiovascular comorbidities (3). These factors increase the risk of postoperative pulmonary complications (PPCs), delayed recovery, prolonged hospitalization, and reduced quality of life (QoL). Accordingly, preoperative functional assessment should be viewed not only as a tool for perioperative risk stratification, but also as a framework for identifying interventions capable of modifying perioperative risk (4). In thoracic oncology, prehabilitation refers to a multimodal strategy implemented before surgery with the goal of optimizing physiologic reserve prior to operative intervention. Such programs may include aerobic exercise, resistance training, respiratory physiotherapy, inspiratory muscle training, nutritional support, psychological counseling, smoking cessation, and optimization of bronchodilator therapy. Unlike postoperative rehabilitation, which primarily focuses on recovery from surgical trauma, prehabilitation aims to prevent perioperative physiologic decompensation and improve resilience to surgical stress (5). Rationale and knowledge gap Despite the growing body of literature, the clinical role of prehabilitation before lung resection for NSCLC remains incompletely defined. An unresolved question is not only whether prehabilitation improves preoperative functional parameters such as 6-minute walk distance (6MWD) or peak oxygen consumption (VO2 peak), but also whether these physiologic improvements translate into clinically meaningful postoperative recovery (6). From a surgical perspective, immediate outcomes of interest include PPCs, length of hospital stay (LOS), intensive care utilization, early mobilization, and recovery from respiratory insufficiency. Equally important, however, are long-term functional outcomes such as exercise tolerance and dyspnea, which influence both QoL and the ability to initiate adjuvant oncologic therapy in a timely manner. Interpretation of the available evidence remains challenging because studies differ substantially with respect to rehabilitation protocols, patient selection, duration of intervention, outcome measures, and integration with enhanced recovery after surgery (ERAS) pathways. Furthermore, the independent contribution of isolated prehabilitation remains difficult to distinguish from the broader effects of continuous perioperative rehabilitation and modern ERAS based perioperative care. Objective The present review summarizes the current literature evaluating the impact of prehabilitation and continuous perioperative rehabilitation on early clinical outcomes and time-specific functional recovery following surgical treatment for NSCLC. The intended added value of this structured narrative review is not to provide another pooled estimate, but to map review-level evidence and primary studies separately, distinguish isolated preoperative prehabilitation from continuous perioperative rehabilitation and ERAS-integrated pathways, and propose a cautious risk-adapted clinical framework for patient selection. We present this article in accordance with the Narrative Review reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1765/rc). Methods This article was designed as a structured narrative review. A structured literature search and thematic evidence synthesis were used to identify and organize clinically relevant evidence. The PICO framework was used to define the clinical scope and outcome domains. The search was intended to provide a transparent and clinically representative evidence base rather than to meet the requirements of an exhaustive systematic review. No prospective protocol registration was performed. The unit of synthesis was defined at the source-type and intervention-category level: review-level evidence was used to describe existing pooled estimates, while primary studies were used to illustrate specific intervention models, target populations, feasibility, and implementation issues. Quantitative pooling was not planned. Evidence was synthesized narratively because the identified sources differed substantially with respect to study design, type and duration of prehabilitation, intervention intensity and setting, patient characteristics, extent of pulmonary resection, surgical approach, integration of ERAS components, timing of outcome assessment, and duration of postoperative follow-up. The synthesis was organized into early clinical outcomes, early functional outcomes, and longer-term functional outcomes. PICO question The clinical question was formulated as follows: does prehabilitation, compared with standard perioperative care, improve early postoperative clinical outcomes and clearly defined functional outcomes following surgical treatment in patients with NSCLC? The PICO components are summarized in Table 1. Population. Adult patients with NSCLC undergoing lung resection, predominantly anatomical pulmonary resections including lobectomy, segmentectomy, bilobectomy, or pneumonectomy. Population. Adult patients with NSCLC undergoing lung resection, predominantly anatomical pulmonary resections including lobectomy, segmentectomy, bilobectomy, or pneumonectomy. Intervention. Preoperative prehabilitation programs including aerobic exercise, resistance training, respiratory physiotherapy, inspiratory muscle training, nutritional support, psychological counseling, smoking cessation, optimization of bronchodilator therapy, and multimodal rehabilitation strategies. Intervention. Preoperative prehabilitation programs including aerobic exercise, resistance training, respiratory physiotherapy, inspiratory muscle training, nutritional support, psychological counseling, smoking cessation, optimization of bronchodilator therapy, and multimodal rehabilitation strategies. Comparison. Standard preoperative care, routine observation, absence of structured prehabilitation, or rehabilitation initiated only after surgery. Comparison. Standard preoperative care, routine observation, absence of structured prehabilitation, or rehabilitation initiated only after surgery. Outcomes. PPCs, overall complications, LOS, the 6-minute walk test (6MWT) as the test procedure, 6MWD as the measured distance, VO2 peak, forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), diffusing capacity of the lung for carbon monoxide (DLCO), dyspnea, QoL, anxiety and depression, program tolerability, and adverse events were considered. Functional outcomes were interpreted separately as preoperative improvement, recovery to preoperative baseline after surgery, postoperative between-group differences, and sustained functional outcomes at 6 months or later. Because the selected sources did not provide consistent data on the timing, initiation, completion, or tolerance of adjuvant oncologic therapy, this outcome was removed from the PICO table and was not retained as an outcome domain in the revised synthesis. Outcomes. PPCs, overall complications, LOS, the 6-minute walk test (6MWT) as the test procedure, 6MWD as the measured distance, VO2 peak, forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), diffusing capacity of the lung for carbon monoxide (DLCO), dyspnea, QoL, anxiety and depression, program tolerability, and adverse events were considered. Functional outcomes were interpreted separately as preoperative improvement, recovery to preoperative baseline after surgery, postoperative between-group differences, and sustained functional outcomes at 6 months or later. Because the selected sources did not provide consistent data on the timing, initiation, completion, or tolerance of adjuvant oncologic therapy, this outcome was removed from the PICO table and was not retained as an outcome domain in the revised synthesis. Table 1Components of the clinical questionComponentContentP, populationAdult patients with NSCLC scheduled for lung resection, predominantly anatomical pulmonary resection (lobectomy, segmentectomy, bilobectomy or pneumonectomy)I, interventionPreoperative prehabilitation: aerobic training, resistance exercise, breathing exercises, inspiratory muscle training, nutritional support, psychological support, smoking cessation, optimization of bronchodilator therapy, and multimodal programsC, comparisonStandard preoperative preparation, usual care, no structured prehabilitation, or rehabilitation initiated only after surgeryO, outcomesPPCs, overall complications, LOS, preoperative changes in functional capacity, postoperative recovery to preoperative baseline, postoperative between-group functional differences, sustained functional outcomes at 6 months or later, 6MWD, VO2 peak, FEV1, FVC, DLCO, dyspnea, QoL, anxiety and depression, program tolerability, and adverse events6MWD, 6-minute walk distance; DLCO, diffusing capacity of the lungs for carbon monoxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; LOS, length of stay; NSCLC, non-small cell lung cancer; PPC, postoperative pulmonary complication; QoL, quality of life; VO2 peak, peak oxygen uptake. Components of the clinical question 6MWD, 6-minute walk distance; DLCO, diffusing capacity of the lungs for carbon monoxide; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; LOS, length of stay; NSCLC, non-small cell lung cancer; PPC, postoperative pulmonary complication; QoL, quality of life; VO2 peak, peak oxygen uptake. Search strategy A structured literature search was conducted using PubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, eLibrary, and professional society websites. The search period extended from January 2019 through February 2026. The search was supplemented by manual review of reference lists and by earlier landmark studies when they were methodologically important or provided essential clinical context. The search strategy was designed to support a comprehensive clinical narrative rather than an exhaustive systematic review. The search strategy included the following terms: “non-small cell lung cancer”, “NSCLC”, “lung cancer”, “lung resection”, “lobectomy”, “segmentectomy”, “pneumonectomy”, “VATS”, “prehabilitation”, “preoperative exercise”, “preoperative pulmonary rehabilitation”, “inspiratory muscle training”, “breathing exercise”, “6 minute walk distance”, “VO2 peak”, “postoperative pulmonary complications”, “quality of life”, and “functional recovery”. The search strategy summary is provided in Table 2. Table 2The search strategy summaryItemsSpecificationDate of SearchFinal search: 28 February 2026Databases and other sources searchedPubMed/MEDLINE, Scopus, Web of Science, Cochrane Library, eLibrary, and professional society websites. Additional records were identified by manual review of reference lists from relevant reviews and key articlesSearch terms usedThe search strategy included the following terms: “non-small cell lung cancer”, “NSCLC”, “lung cancer”, “lung resection”, “lobectomy”, “segmentectomy”, “pneumonectomy”, “VATS”, “prehabilitation”, “preoperative exercise”, “preoperative pulmonary rehabilitation”, “inspiratory muscle training”, “breathing exercise”, “6 minute walk distance”, “VO2 peak”, “postoperative pulmonary complications”, “quality of life”, and “functional recovery”. A detailed PubMed/MEDLINE search strategy is provided as a Table S1. Direct PubMed validation returned 161 records for the primary sensitive query and 136 records for the focused outcome-sensitive checking queryTimeframeJanuary 2019 through February 2026. Earlier landmark studies were considered when referenced in major systematic reviews or meta-analyses as methodologically importantInclusion and exclusion criteriaSources considered for the core narrative synthesis: randomized controlled trials, systematic reviews, meta-analyses, prospective and retrospective comparative studies evaluating prehabilitation or perioperative rehabilitation in NSCLC or surgical lung cancer cohorts with at least one postoperative clinical or functional outcome. English- and Russian-language publications were considered. Sources not used as direct evidence: studies without surgical treatment, studies focused exclusively on postoperative rehabilitation without a preoperative component, studies without relevant outcomes, protocols without results, nonrelevant tumor types, editorials, commentaries, and expert opinions without primary dataSelection processRecords were reviewed in two stages: title and abstract review followed by full-text assessment. Two investigators (Y.S.E. and E.A.T.) reviewed potentially relevant sources, and disagreements were resolved through discussion. Duplicate removal and record management were performed using a bibliographic management platform. This process was used to improve consistency and transparency within a narrative review and was not intended as formal systematic-review screeningAny additional considerationsNo quantitative pooling, formal risk-of-bias assessment, or formal certainty grading was performed. Methodological strengths, limitations, and clinical applicability were considered narratively. Professional society guidelines were used for clinical interpretation but were not treated as direct evidence of intervention effectiveness. No prospective protocol registration was performedNSCLC, non-small cell lung cancer. The search strategy summary NSCLC, non-small cell lung cancer. Source selection criteria Priority was given to randomized controlled trials, systematic reviews, meta-analyses, prospective and retrospective comparative studies evaluating prehabilitation or perioperative rehabilitation in patients with NSCLC or surgical lung cancer cohorts. Sources were included in the core narrative synthesis when they reported at least one postoperative clinical or functional outcome relevant to the review question. Sources were not used as direct evidence when they did not involve surgical treatment, focused exclusively on delayed postoperative rehabilitation without a preoperative component, lacked relevant clinical or functional outcomes, represented protocols without results, involved nonrelevant tumor types, or consisted of editorials, commentaries, or expert opinions without primary data. Guidelines from ERAS/ESTS, ERS/ESTS, and ASCO were used for clinical interpretation and discussion of perioperative pathways but were not considered direct evidence regarding the effect of prehabilitation on surgical outcomes. Outcome domains The main domains of interest were PPCs and time-specific functional outcomes assessed using 6MWD, VO2 peak, or comparable exercise-capacity tests. Functional endpoints were interpreted as distinct constructs: improvement in functional capacity before surgery, recovery to the preoperative baseline after surgery, postoperative differences between intervention and control groups, and sustained functional benefit at 6 months or later. Outcomes assessed at approximately 4 to 12 weeks were treated as early or intermediate postoperative recovery rather than long-term recovery. Additional domains included LOS, overall complication rates, pulmonary function parameters, dyspnea, QoL, program tolerability, and adverse events. Tolerance of subsequent oncologic therapy was not retained as an outcome domain because the selected sources did not report this outcome sufficiently or consistently. Source identification and selection The structured search identified 384 records. An additional 7 publications were identified through manual review of reference lists from relevant reviews and key articles. After removal of 96 duplicates, 295 records remained for title and abstract review. Of these, 257 publications were excluded. Full-text review was performed for 38 studies; 24 publications were not used for the core narrative synthesis. Fourteen sources were selected for the core narrative synthesis. Six contextual sources were used separately for clinical interpretation and were not treated as direct evidence of intervention effectiveness. Records were reviewed in two stages consisting of title and abstract review followed by full-text assessment of potentially relevant publications. Two investigators (Y.S.E. and E.A.T.) reviewed the records, and disagreements were resolved through discussion. A bibliographic management platform was used for record management and duplicate removal. The source-identification process is summarized in Figure 1. Contextual sources are presented separately from full-text sources not used for the core synthesis, and the figure is labelled as a source-identification flow diagram rather than as a systematic-review flow diagram. Source categories and their roles in the synthesis are summarized in Table 3. Summary of source identification for the structured narrative review. NSCLC, non-small cell lung cancer. Table 3Source categorization used in the structured narrative reviewCategoryNumberSourcesRole in synthesisCore narrative synthesis: review-level evidence3Granger and Cavalheri, 2022 (7); Voorn et al., 2023 (6); Guo et al., 2025 (8)Used to describe the broad evidence base and published pooled estimates. These estimates were not added to or treated as independent from overlapping primary studiesCore narrative synthesis: randomized trials6Brat et al., 2025 (5); Liu et al., 2020 (9); Bhatia and Kayser, 2019 (10); Ferreira et al., 2021 (11); Yao et al., 2023 (12); Tenconi et al., 2021 (13)Used to map trial-level intervention models, target populations, timing of outcome assessment, and recent or clinically illustrative findings; not treated as independent confirmation of pooled estimates when overlap was possibleCore narrative synthesis: observational, propensity-matched, feasibility, and implementation studies5Cho et al., 2025 (14); Goldsmith et al., 2021 (15); Schmid et al., 2022 (16); Ricketts et al., 2020 (17); ten Cate et al., 2024 (18)Used to characterize real-world implementation, high-risk populations, operability, feasibility, and clinical applicability; interpreted separately from randomized evidenceContextual clinical sources outside the core synthesis4Galkin et al., 2023 (1); Samsonik et al., 2024 (2); Deng et al., 2024 (3); Toneev et al., 2024 (4)Used for background, risk stratification, and clinical interpretation; not counted as direct intervention-effect evidenceProfessional guideline/interpretive reference1Brunelli et al., 2025 (19)Used to support functional-assessment and patient-selection terminology; not counted as intervention-effect evidenceContextual postoperative rehabilitation evidence1Wang et al., 2026 (20)Used only to inform interpretation of sustained postoperative functional recovery; not treated as direct evidence of preoperative prehabilitation effectiveness Source categorization used in the structured narrative review Evidence charting Two investigators (Y.S.E. and E.A.T.) charted key information from the selected sources using a standardized form. The charted items included study design, country and study period, population characteristics, sample size, type of surgical intervention, structure of the prehabilitation or perioperative rehabilitation program, comparator group, timing of outcome assessment, clinical and functional outcomes, intervention safety, and principal study limitations. The charted information was cross-checked, discrepancies were resolved through discussion, and the final data were incorporated into a summary evidence table. The charted evidence is summarized in Table S2. Critical appraisal and interpretation of evidence The methodological strengths, limitations, and clinical applicability of the selected sources were appraised narratively. Considerations included study design, sample size, patient population, intervention structure, presence of comparator groups, completeness of outcome reporting, duration of follow-up, and limitations acknowledged by the study authors. For randomized studies, attention was directed to group allocation, baseline comparability, completeness of reported data, selective reporting, and the practical inability to fully blind rehabilitation interventions. For nonrandomized studies, selection bias, between-group differences, residual confounding, and limits to causal inference were considered. For systematic reviews and meta-analyses, the search strategy, eligibility criteria, management of heterogeneity, assessment of bias in primary studies, and applicability to patients undergoing lung resection for NSCLC were considered. A narrative appraisal of the principal outcome domains is presented in Table S3. Formal risk-of-bias tools, including RoB 2, ROBINS-I, and AMSTAR 2, were not applied. GRADE was not used, and no formal certainty ratings were assigned. Methodological judgments were used only to support a clinically oriented narrative interpretation and not to generate reproducible evidence grades or formal recommendations. Narrative synthesis Evidence was synthesized thematically and hierarchically, with review-level evidence and primary studies kept conceptually separate. Existing systematic reviews and meta-analyses were used to summarize the broad evidence base and published pooled estimates. Individual randomized trials, cohort studies, propensity-matched analyses, feasibility studies, and implementation studies were not treated as independent confirmation of pooled review-level estimates when overlap with reviews was possible. Instead, they were used to map intervention type, patient selection, timing, feasibility, and clinical applicability. No pooled estimate was calculated in the present review, and overlapping evidence was managed by explicitly separating review-level synthesis from primary-study interpretation. Intervention categories were also separated during interpretation because exercise-only prehabilitation, inspiratory muscle training, multimodal prehabilitation, continuous perioperative rehabilitation, rehabilitation during neoadjuvant therapy, ERAS-integrated pathways, and predominantly postoperative rehabilitation differ in timing, content, intensity, and expected outcomes. These intervention categories are summarized in Table 4; a supplementary overview is provided in Table S4. Table 4Intervention categories considered during narrative synthesisIntervention categoryRepresentative sourcesHow it was interpretedReview-level evidence of preoperative exercise or pulmonary rehabilitationGranger and Cavalheri, 2022 (7); Voorn et al., 2023 (6); Guo et al., 2025 (8)Used to summarize existing pooled evidence; not combined again with overlapping primary studiesIsolated preoperative exercise trainingBhatia and Kayser, 2019 (10)Used to evaluate the effect of short preoperative exercise training on physiologic readiness and functional capacity; findings were not generalized to multimodal prehabilitation componentsMultimodal prehabilitation before surgeryBrat et al., 2025 (5); Liu et al., 2020 (9); Yao et al., 2023 (12); Cho et al., 2025 (14); ten Cate et al., 2024 (18)Interpreted as combined exercise, respiratory, nutritional, psychological, and/or smoking-cessation optimization; causal inference depends on study designContinuous perioperative rehabilitationFerreira et al., 2021 (11); Tenconi et al., 2021 (13)Interpreted separately because postoperative continuation may drive later functional outcomesPrehabilitation during neoadjuvant therapy or borderline-operability optimizationSchmid et al., 2022 (16); Goldsmith et al., 2021 (15); Ricketts et al., 2020 (17)Used for implementation, operability, and high-risk pathway considerations rather than universal efficacy claimsPredominantly postoperative rehabilitationWang et al., 2026 (20)Used only as contextual evidence for prolonged recovery after lung resection; not treated as direct evidence of preoperative prehabilitation effectivenessERAS-integrated perioperative pathways and guidelinesBrunelli et al., 2025 (19); professional society guidanceUsed to frame functional assessment and patient selection; not treated as intervention-effect evidenceERAS, enhanced recovery after surgery. Intervention categories considered during narrative synthesis ERAS, enhanced recovery after surgery. During interpretation, studies evaluating isolated preoperative prehabilitation, continuous perioperative rehabilitation programs, and ERAS integrated pathways were analyzed separately, as the contribution of these components to early and long-term outcomes may differ. Because the review-level sources included overlapping primary studies, their pooled estimates were presented separately and were not combined or interpreted as independent replication of the same underlying evidence. Source identification and selection Of the 391 records identified through electronic database and manual searches, 295 publications remained after duplicate removal for title and abstract review. At this stage, 257 publications were excluded because of the absence of a surgical NSCLC cohort (n=88), lack of a prehabilitation component before surgery (n=74), absence of functional or clinical outcome data (n=51), or inappropriate study design including editorials and commentaries (n=44). Full-text review was performed for 38 studies. Twenty-four publications were subsequently not used for the core narrative synthesis because they evaluated postoperative rehabilitation without a preoperative component (n=7), included mixed pulmonary resection cohorts without separate NSCLC analysis (n=6), provided insufficient outcome detail (n=5), represented duplicate cohorts (n=3), or consisted of study protocols, conference abstracts, or publications without accessible full text (n=3). Fourteen sources were selected for the core narrative synthesis. The source-identification process is summarized in Figure 1. These reasons are also summarized in Table S5. The 14 core sources comprised three review-level sources, six randomized trials, and five observational, propensity-matched, feasibility, or implementation studies. Six additional sources were used outside the core synthesis for contextual interpretation. These included four clinical background sources, Galkin et al. (1), Samsonik et al. (2), Deng et al. (3), and Toneev et al. (4), one postoperative-rehabilitation review, Wang et al. (20), and one professional guideline, Brunelli et al. (19). None was treated as direct evidence of preoperative prehabilitation effectiveness. To reduce the risk of double counting, review-level sources were used for overall evidence mapping and published pooled estimates, whereas primary studies were discussed separately for intervention-specific interpretation. The review did not combine pooled estimates from meta-analyses with individual study estimates from overlapping trial populations. Impact on PPCs Evidence regarding PPCs was interpreted first at the review level and then at the level of selected primary studies. This separation was used to avoid treating systematic reviews and the individual trials within them as independent bodies of evidence. At the review level, the 2022 Cochrane review by Granger and Cavalheri included 10 randomized controlled trials and 636 patients with NSCLC and reported a reduced risk of PPCs with preoperative exercise interventions (RR 0.45; 95% CI: 0.33 to 0.61), with probable shortening of hospital length of stay and improvement in VO2 peak (7). Similarly, the 2025 meta-analysis by Guo et al. included 11 randomized trials and 1250 patients and reported a reduction in PPCs (RR 0.39; 95% CI: 0.25 to 0.60; P<0.001) and a modest improvement in QoL (8). However, Guo et al. did not demonstrate a significant overall reduction in hospital length of stay, and LOS was therefore interpreted cautiously as an endpoint influenced by ERAS protocols, discharge criteria, and local health-care organization. At the level of individual randomized evidence, the multicenter randomized trial by Brat et al. was incorporated into the core synthesis because it directly evaluated high-risk patients undergoing lung resection. In that trial, high risk was defined by ventilatory inefficiency on cardiopulmonary exercise testing (CPET) (VE/VCO2 slope ≥33), and 122 patients completed follow-up. A 14-day multimodal prehabilitation program incorporating high-intensity respiratory muscle training, smoking cessation, nutritional support, and psychological support reduced PPCs compared with usual care (20/58, 34% vs. 35/64, 55%; P=0.03) and shortened hospital length of stay {7 [6–9] vs. 9 [7–11] days; P=0.04} (5). Cho et al. was incorporated into the main synthesis as contemporary propensity-score-matched real-world evidence after verification of the published sample-size and outcome data. Among 1,242 potentially eligible patients undergoing lung cancer surgery, 555 were selected for propensity-score matching, yielding 147 matched pairs per group. Compared with controls, the prehabilitation group had lower rates of overall complications (46.3% vs. 65.3%; P=0.001), major complications (13.6% vs. 27.9%; P=0.003), intensive care unit admission (2.7% vs. 8.2%; P=0.04), and readmission (6.1% vs. 14.3%; P=0.02), as well as a lower Comprehensive Complication Index. Because of its retrospective design and referral-based patient selection, this study was interpreted as observational implementation evidence rather than randomized evidence (14). Collectively, these findings support a risk-adapted rather than universal model of prehabilitation, in which intensive preoperative rehabilitation is prioritized for patients at highest risk of PPCs. Reduced FEV1, DLCO, 6MWD, or VO2 peak may help identify patients at increased risk of respiratory morbidity and delayed recovery. In such patients, prehabilitation should be viewed not merely as an adjunct physiotherapy intervention, but as an attempt to modify perioperative risk through improvement of exercise tolerance and physiologic reserve. This approach appears particularly relevant in patients with COPD, impaired diffusion capacity, sarcopenia, advanced age, significant dyspnea, or planned extended pulmonary resections. Impact on early functional outcomes The occurrence of PPCs does not necessarily correlate directly with changes in physiologic or laboratory parameters during the early or delayed postoperative period. Nevertheless, assessment of functional outcomes may indirectly reflect the effectiveness of perioperative rehabilitation strategies. The most commonly evaluated parameters included the 6MWT as the testing procedure, 6MWD as the measured distance, pulmonary function testing, dyspnea severity, QoL, psychologic outcomes, VO2 peak, and other CPET variables. In most studies, improvements in functional parameters were observed either before surgery or within the first postoperative month. However, the magnitude of benefit varied according to baseline functional risk, rehabilitation intensity, and the presence of continued postoperative support. In a randomized trial by Liu et al., 73 patients undergoing thoracoscopic lobectomy for NSCLC were assigned to either a 2-week home-based multimodal prehabilitation program or standard care. The intervention included aerobic and resistance exercises, respiratory training, whey protein supplementation, and psychologic support. Patients in the prehabilitation group demonstrated a 60.9 m greater improvement in 6MWD compared with controls (95% CI: 32.4 to 89.5; P<0.001), as well as a 0.35 L higher FVC (95% CI: 0.05 to 0.66; P=0.02). However, no differences in hospital length of stay, postoperative complications, or mortality were identified (9). Interpretation of these findings requires caution because the study population consisted predominantly of functionally preserved patients without substantial comorbidity and therefore at relatively low perioperative risk. In the randomized study by Bhatia and Kayser, 151 patients undergoing lung resection were randomized to high-intensity interval training or standard preoperative care. Median waiting time before surgery in the intervention group was 25 days, during which patients completed a median of 8 exercise sessions. The program was feasible, demonstrated high adherence, and improved cardiopulmonary performance including exercise testing parameters and 6MWD (10). However, the baseline VO2 peak was approximately 20 mL/kg/min, suggesting a largely functionally preserved low-risk population. Ferreira et al. randomized 95 patients to either 4 weeks of multimodal prehabilitation before surgery or multimodal rehabilitation initiated after surgery; all patients were treated within an ERAS pathway. No significant between group differences were observed in postoperative exercise tolerance or pulmonary function parameters, and more than 75% of patients in both groups recovered to baseline functional status by 8 weeks (11). These findings suggest that within established ERAS programs and active postoperative rehabilitation pathways, the incremental value of isolated preoperative prehabilitation in low-risk patients may be limited. In the study by Yao et al., trimodal prehabilitation before thoracoscopic lung resection for NSCLC improved 6MWD, reduced anxiety and depression, shortened hospital stay, and decreased postoperative complications, predominantly atelectasis (12). These findings support a multimodal approach to preoperative optimization but should be interpreted in the context of a single-center study design, inclusion of patients with resectable stage I and II disease, age restriction below 75 years, and exclusion of patients with severe comorbidities. Importantly, improvements in 6MWD, VO2 peak, or isolated pulmonary function parameters before surgery do not necessarily translate directly into measurable reductions in postoperative complications. Among functionally preserved low-risk patients, particularly within ERAS pathways, complication rates may be too low to detect additional clinical benefit from prehabilitation. Among patients with impaired cardiopulmonary reserve, even modest improvements in exercise tolerance may be clinically relevant, but this remains a risk-adapted interpretation that should be tested prospectively rather than a validated rule. Impact on intermediate and long-term functional outcomes Assessment of postoperative functional outcomes requires time-specific interpretation. In the revised synthesis, outcomes at 4 to 12 weeks were described as early or intermediate postoperative recovery, whereas outcomes assessed at 6 months or later were described as long-term. Four clinically distinct endpoints were separated: improvement in functional capacity before surgery, recovery to the preoperative baseline after surgery, postoperative between-group differences, and sustained improvement beyond 6 months. These outcomes were not combined under a single general conclusion that prehabilitation improves functional recovery. The most informative study regarding sustained functional recovery is the randomized PUREAIR trial by Tenconi et al., which included 140 patients assigned to standard care or continuous perioperative rehabilitation. The program incorporated 14 preoperative and 39 postoperative rehabilitation sessions. At 30 days, no significant differences were observed in complications, hospital stay, pulmonary function, QoL, or anxiety. However, at 6 months, patients in the perioperative rehabilitation group demonstrated superior exercise tolerance: 6MWD increased by 48.9 m, whereas it decreased by 7.5 m in the control group (95% CI: 29.6 to 83.0; P<0.001) (13). The PUREAIR results should not be interpreted as evidence of an isolated preoperative effect. Rather, the study supports the concept of continuous perioperative rehabilitation extending beyond surgery. Accordingly, durable functional benefit appears more likely to result from sustained perioperative rehabilitation rather than from short isolated preoperative interventions alone. Similarly, the meta-analysis by Guo et al. emphasized the importance of prolonged follow-up when evaluating delayed effects of prehabilitation, as most included studies reported outcomes only 2 to 6 weeks after surgery (8). The systematic review by Wang et al., focused predominantly on postoperative pulmonary rehabilitation after lung resection, demonstrated greater functional benefit with rehabilitation programs lasting at least 12 weeks, further supporting the rationale for continuous perioperative rehabilitation strategies (20). High risk patients and patient selection The clinical benefit of prehabilitation is unlikely to be uniform across patient populations, but the available studies do not directly compare universal with risk-adapted prehabilitation and do not establish a formal treatment-by-baseline-risk interaction. Therefore, patient selection should be interpreted as a clinically plausible implementation principle rather than a validated predictive rule. Specific thresholds for predicted postoperative FEV1, DLCO, VO2 peak, 6MWD, and dyspnea scores should not be interpreted in isolation but rather incorporated into accepted functional assessment algorithms, as current guidelines do not support reliance on a single parameter when determining operability or extent of resection (19). Among functionally preserved patients treated within ERAS pathways, the additional clinical value of intensive prehabilitation may be limited. In these patients, basic counseling, smoking cessation, respiratory exercises, routine ambulation, optimization of bronchodilator therapy, and early postoperative mobilization may be sufficient. This concept is supported by the study by Goldsmith et al., which demonstrated the potential role of prehabilitation among functionally compromised or initially inoperable patients. After 2 to 4 weeks of pulmonary rehabilitation, most patients demonstrated reduced dyspnea, an approximately 54 m improvement in 6MWD, and improved functional status. Importantly, 69.4% of patients initially considered functionally inoperable or borderline operable subsequently became candidates for surgical treatment. Although this was not a randomized study, it remains clinically important because it suggests that prehabilitation may allow selected high-risk patients to transition into operable status, which may be particularly relevant when considering multimodality or induction therapy approaches (15). In the study by Schmid et al., prehabilitation during neoadjuvant treatment for locally advanced NSCLC was associated with an approximately 33 m improvement in 6MWD and reduction in symptom burden (16). Safety and feasibility The available studies generally reported no major adverse events related to short prehabilitation programs; however, this should be interpreted as a feasibility and tolerability signal rather than definitive evidence of safety. Many studies were not powered to detect uncommon adverse events, and adverse events or delays in oncologic treatment were not always prospectively or uniformly captured. Therefore, implementation should include monitoring for treatment delay, exercise-related adverse events, and adherence. Ricketts et al. evaluated implementation of a preoperative optimization service for lung cancer surgery. More than 78% of patients had severe COPD, 43% demonstrated low or critically reduced pulmonary function parameters, and the mean Medical Research Council dyspnea score was 3.75. The program included optimization of inhaled therapy, smoking cessation, and pulmonary rehabilitation with aerobic and resistance exercises. Following intervention, improvements in FEV1 and 6MWD were observed, and the authors emphasized the potential role of prehabilitation in improving operability among high-risk patients (17). This study was therefore categorized as a core feasibility and implementation source rather than as a contextual source, because it reported outcomes from an actual preoperative optimization service in a surgical lung cancer population (17). In the feasibility study by ten Cate et al., 42 of 131 patients referred for surgical treatment of NSCLC met inclusion criteria for prehabilitation, and 24 patients were ultimately included in the final analysis. All participants completed the program, adherence exceeded 80% in 23 of 24 patients, no adverse events were observed, and surgery was successfully performed within the target interval of 3 to 5 weeks in 20 patients (18). These findings support the feasibility of short multimodal rehabilitation programs but should not be interpreted as direct evidence of clinical efficacy. Importantly, successful implementation of perioperative rehabilitation programs depends on numerous factors including local healthcare infrastructure, financial resources, availability of specialized personnel such as physiotherapists, pulmonologists, and nutritionists, access to psychologic support and remote monitoring, as well as establishment of standardized risk stratification and perioperative rehabilitation pathways. Discussion Prehabilitation before lung resection for NSCLC is most consistently associated with reduced PPCs and improved early postoperative recovery. These findings are physiologically plausible and align with the proposed mechanisms of intervention, including respiratory and skeletal muscle conditioning, improved exercise tolerance and ventilation, reduction in dyspnea, correction of nutritional deficiencies, and psychologic preparation before surgery. The recent multicenter randomized trial by Brat et al. is particularly relevant to this interpretation because it enrolled patients at increased risk of PPCs and demonstrated both a lower PPC rate and shorter hospital stay after a short multimodal program. This trial strengthens the argument that patient selection by baseline physiologic risk may be clinically important, but it should be interpreted as supportive evidence for a risk-adapted hypothesis rather than as validation of a universal patient-selection algorithm (5). However, the currently available evidence does not support the conclusion that isolated preoperative intervention alone consistently improves long-term functional outcomes following thoracic oncologic surgery. Evidence regarding recovery beyond 6 months remains limited, and the most convincing results have been observed in studies where preoperative conditioning continued into the postoperative period. Consequently, it remains difficult to distinguish the independent contribution of prehabilitation from the broader effects of continuous perioperative rehabilitation and ERAS implementation. PPCs represent the most consistently reported early endpoint. In contrast, hospital length of stay should be interpreted more cautiously because it is influenced by ERAS implementation, discharge criteria, bed availability, and local postoperative pathways. For example, not all meta-analyses demonstrated a significant overall reduction in hospital length of stay. Long-term functional recovery is influenced by extent of pulmonary resection, surgical approach, postoperative complications, adjuvant therapy, severity of underlying comorbidities, social support, patient motivation, and continuation of exercise programs after discharge. Timing of assessment also varied substantially, ranging from immediate preoperative evaluation to 4 to 8 weeks and 6 months after surgery, which limits direct comparison between studies. An important finding of the present review is the need to interpret isolated prehabilitation, continuous perioperative rehabilitation, and ERAS pathways as related but distinct concepts. Isolated prehabilitation primarily aims to increase physiologic reserve before surgery and reduce the risk of early postoperative decompensation. Continuous perioperative rehabilitation additionally targets recovery after discharge and therefore may have greater relevance for long-term functional outcomes. ERAS pathways establish a baseline standard for perioperative care and may diminish the observable incremental effect of prehabilitation among low-risk patients. Evidence from one intervention category was therefore not generalized automatically to other categories. These considerations support evaluating different levels of rehabilitation intensity within contemporary ERAS-based pathways rather than comparing prehabilitation with outdated or nonstandard perioperative care. However, the available evidence does not establish that risk-adapted implementation is superior to universal prehabilitation. Therefore, the framework below is presented as a pragmatic, author-proposed structure for clinical implementation and future testing. Future research should preferentially focus on high-risk populations including patients with COPD, impaired DLCO, reduced VO2 peak, sarcopenia, advanced age, severe dyspnea, borderline operability, prior neoadjuvant therapy, or planned extended pulmonary resections. Based on this interpretation, we propose a three-tier author-proposed clinical framework for risk-adapted implementation of prehabilitation in thoracic oncology pathways (Table 5). Table 5Author-proposed clinical framework for risk-adapted implementation of prehabilitationLevelProgram contentTarget groupBasic level for all patientsSmoking cessation; instruction in breathing exercises; daily walking; optimization of obstructive airway disease and bronchodilator therapy; basic nutritional assessment; education regarding early postoperative mobilization.Patients with preserved functional status, low-risk of complications, and planned standard resection within an ERAS pathway.Targeted level for intermediate-risk patients2–4 weeks of aerobic training; resistance exercise; breathing exercises; nutritional support; remote or in-person monitoring of exercise tolerance.Patients with moderately reduced physiologic reserve, mild or moderate COPD, reduced exercise tolerance, or expected postoperative functional decline, interpreted in conjunction with accepted functional assessment algorithms rather than a single threshold.Intensive level for high-risk patientsMultidisciplinary program involving a thoracic surgeon, pulmonologist, physiotherapist, nutritionist, anesthesiologist, and psychologist; monitoring may include 6MWD, mMRC/Borg, SpO2, exercise tolerance, and adherence; postoperative continuation for at least 8–12 weeks.Functionally borderline patients, severe COPD, reduced ppoFEV1/ppoDLCO, low VO2 peak, sarcopenia, advanced age, neoadjuvant therapy, bilobectomy, or pneumonectomy; these criteria are proposed for clinical stratification and require prospective validation.6MWD, 6-minute walk distance; COPD, chronic obstructive pulmonary disease; ERAS, enhanced recovery after surgery; mMRC, modified medical research council; ppoDLCO, predicted postoperative diffusing capacity of the lungs for carbon monoxide; ppoFEV1, predicted postoperative forced expiratory volume in 1 second; SpO2, peripheral oxygen saturation; VO2 peak, peak oxygen uptake. Author-proposed clinical framework for risk-adapted implementation of prehabilitation 6MWD, 6-minute walk distance; COPD, chronic obstructive pulmonary disease; ERAS, enhanced recovery after surgery; mMRC, modified medical research council; ppoDLCO, predicted postoperative diffusing capacity of the lungs for carbon monoxide; ppoFEV1, predicted postoperative forced expiratory volume in 1 second; SpO2, peripheral oxygen saturation; VO2 peak, peak oxygen uptake. The framework separates evidence-based findings from expert clinical interpretation. Evidence supports early pulmonary morbidity reduction for selected prehabilitation programs, whereas the proposed allocation of basic, targeted, and intensive levels reflects author interpretation informed by functional-assessment guidance and requires prospective validation. The principal limitation of the present review was the substantial clinical and methodological heterogeneity of the included studies. Rehabilitation programs differed with respect to duration, intensity, setting, intervention components, degree of specialist supervision, nutritional support, and continuation after surgery. In addition, studies varied according to surgical approach, extent of pulmonary resection, baseline functional status, and proportion of high-risk patients. Accordingly, a formal meta-analysis was not performed, and conclusions were based on qualitative synthesis of the available evidence. Additional limitations include inconsistent stratification according to NSCLC histologic subtype, heterogeneous timing of long-term functional assessment, and limited duration of follow-up in many studies, which was frequently restricted to the early postoperative period. Small sample sizes and the inability to fully blind rehabilitation interventions should also be considered when interpreting the robustness of the findings. Consequently, the strongest conclusions of the present review relate primarily to early clinical and functional outcomes, whereas the effect of prehabilitation on long-term recovery remains less definitively established. Because this article was designed as a structured narrative review, no prospective protocol registration, formal risk-of-bias assessment, or GRADE certainty grading was performed. The methodological appraisal was therefore descriptive and clinically oriented, and no formal certainty labels were assigned. The findings should be interpreted as a transparent narrative synthesis intended to map the evidence, identify clinically relevant patterns, distinguish overlapping evidence sources and intervention categories, and generate testable hypotheses rather than as pooled effect estimates or formally graded recommendations. Absence of reported serious adverse events was not interpreted as moderate-certainty safety evidence because adverse-event capture was heterogeneous across studies. Conclusions Prehabilitation before lung resection in patients with NSCLC appears clinically feasible and may reduce early postoperative pulmonary morbidity when appropriately structured. Its implementation should be coordinated to avoid unnecessary delay in oncologic treatment. The most consistent evidence relates to PPCs, whereas effects on mortality, uncommon adverse events, long-term QoL, and sustained functional recovery remain less certain. In the Brat et al. multicenter randomized trial, a 14-day multimodal program reduced early pulmonary morbidity and hospital length of stay among physiologically high-risk patients (5). Functional outcomes should be interpreted according to timing and endpoint definition. Preoperative improvement in exercise capacity, postoperative recovery to baseline, postoperative between-group differences, and sustained improvement at 6 months or later are clinically distinct outcomes. Current evidence does not establish that isolated preoperative intervention alone consistently improves sustained long-term functional outcomes. Patients with impaired physiologic reserve or elevated PPC risk may be reasonable candidates for targeted prehabilitation. However, current evidence does not establish that the treatment effect is greater in these patients than in lower-risk patients. Accordingly, the proposed risk-adapted perioperative rehabilitation pathway should be regarded as a pragmatic author-proposed framework requiring prospective validation. Supplementary The article’s supplementary files as Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1765/prf